Sun H. Hwang

Gwangju, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Effectiveness and Safety of Biodegradable Polymer-Coated Everolimus-Eluting Stent in Multivessel Coronary Artery Disease in Routine Clinical Practice: A Korean Multicenter, Prospective, and Observational Study.

Effectiveness and Safety of Biodegradable Polymer-Coated Everolimus-Eluting Stent in Multivessel Coronary Artery Disease in Routine Clinical Practice: A Korean Multicenter, Prospective, and Observational Study.

Journal: Journal of Korean medical science

Published: December 24, 2024

Impact of Clinic Blood Pressure Target on the Prevalence and Predictors of Masked Uncontrolled Hypertension and White-Coat Uncontrolled Hypertension.

Impact of Clinic Blood Pressure Target on the Prevalence and Predictors of Masked Uncontrolled Hypertension and White-Coat Uncontrolled Hypertension.

Journal: Journal of Korean medical science

Published: August 15, 2024

Clinical Outcome after Everolimus-Eluting Stent Implantation for Small Vessel Coronary Artery Disease: XIENCE Asia Small Vessel Study.

Clinical Outcome after Everolimus-Eluting Stent Implantation for Small Vessel Coronary Artery Disease: XIENCE Asia Small Vessel Study.

Journal: Chonnam medical journal

Published: May 30, 2023

Clinical features and predictors of masked uncontrolled hypertension from the Korean Ambulatory Blood Pressure Monitoring Registry.

Clinical features and predictors of masked uncontrolled hypertension from the Korean Ambulatory Blood Pressure Monitoring Registry.

Journal: The Korean journal of internal medicine

Published: December 07, 2020

Effectiveness and Safety of Zotarolimus-Eluting Stent (Resolute™ Integrity) in Patients with Diffuse Long Coronary Artery Disease.

Effectiveness and Safety of Zotarolimus-Eluting Stent (Resolute™ Integrity) in Patients with Diffuse Long Coronary Artery Disease.

Journal: Korean circulation journal

Published: January 06, 2019

Safety and Efficacy of the Endeavor Resolute® Stent in Patients with Multivessel Disease: The HEART (Honam EndeAvor ResoluTe) Prospective, Multicenter Trial.

Safety and Efficacy of the Endeavor Resolute® Stent in Patients with Multivessel Disease: The HEART (Honam EndeAvor ResoluTe) Prospective, Multicenter Trial.

Journal: Chonnam medical journal

Published: December 31, 2017

The hyaluronic acid-rich node and duct system is a structure organized for innate immunity and mediates the local inflammation.

The hyaluronic acid-rich node and duct system is a structure organized for innate immunity and mediates the local inflammation.

Journal: Cytokine

Published: December 22, 2017

Effectiveness and Safety of Biolimus A9™-Eluting stEnt in Patients with AcUTe Coronary sYndrome; A Multicenter, Observational Study (BEAUTY Study).

Effectiveness and Safety of Biolimus A9™-Eluting stEnt in Patients with AcUTe Coronary sYndrome; A Multicenter, Observational Study (BEAUTY Study).

Journal: Yonsei medical journal

Published: July 21, 2017

Early versus late thrombolysis in acute arterial occlusion of lower extremity.

Early versus late thrombolysis in acute arterial occlusion of lower extremity.

Journal: International journal of cardiology

Published: June 16, 2016

The CHA2DS2VASc score can be used to stratify the prognosis of acute myocardial infarction patients irrespective of presence of atrial fibrillation.

The CHA2DS2VASc score can be used to stratify the prognosis of acute myocardial infarction patients irrespective of presence of atrial fibrillation.

Journal: Journal of cardiology

Published: February 18, 2014

The impact of Agent Orange on characteristics of coronary artery lesion and repeat revascularization.

The impact of Agent Orange on characteristics of coronary artery lesion and repeat revascularization.

Journal: International journal of cardiology

Published: February 13, 2014

Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.

Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.

Journal: JACC. Cardiovascular interventions

Published: September 20, 2013

Showing 1-12 of 17

Last Updated: 09/26/2026